Welgene Biotech Co (ROCO:6661) Retained Earnings: NT$-9.6 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ROCO:6661 Welgene Biotech Co Ltd ROCO:6661
71 GF Score
Price NT$17.20
GF Value NT$29.10
Valuation Possible Value Trap
! 6 Warning Signs
View Full Analysis

What is Welgene Biotech Co Retained Earnings?

Welgene Biotech Co ROCO:6661 71 Retained Earnings is NT$-9.6 Mil as of Jun. 2026. GuruFocus rates ROCO:6661 with a GF Score™ of 71/100 and a GF Value™ of NT$29.10 (Possible Value Trap). The stock has 6 warning signs investors should review.

Retained earnings is the accumulated portion of net income that is not distributed to shareholders. Welgene Biotech Co's retained earnings for the quarter that ended in Jun. 2026 was NT$-9.6 Mil.

Welgene Biotech Co's quarterly retained earnings declined from Dec. 2025 (NT$-1.7 Mil) to Mar. 2026 (NT$-7.9 Mil) and declined from Mar. 2026 (NT$-7.9 Mil) to Jun. 2026 (NT$-9.6 Mil).

Welgene Biotech Co's annual retained earnings increased from Dec. 2023 (NT$-3.4 Mil) to Dec. 2024 (NT$-2.3 Mil) and increased from Dec. 2024 (NT$-2.3 Mil) to Dec. 2025 (NT$-1.7 Mil).


Welgene Biotech Co  (ROCO:6661) Retained Earnings Explanation

Historically profitable companies sometimes have negative retained earnings. This is because they have cumulatively paid out more to shareholders than they reported in profits.

For example, in 2011, Microsoft had negative retained earnings. This does not mean the company lost more money than it made over the years. It just means it paid out more money than it earned.

If a company has negative retained earnings, investors should check the 10-year financial results. They should not assume that negative retained earnings prove a company has generally lost money in the past.

Of course, many companies with negative retained earnings have indeed lost money in the past.

Retained Earnings: Warren Buffett's Secret.

One of the most important indicators of durable competitive advantage. Net earnings can be paid out as dividends, used to buy back shares or retained for growth.

If the company loses more than it has accumulated, retained earnings is negative.

If a company isn't adding to its retained earnings, it isn't growing its net worth.

Rate of growth of retained earnings is good indicator whether it's benefiting from a competitive advantage.

Microsoft is negative because it chose to buyback stock and pay dividends.

The more earnings retained, the faster it grows and increases growth rate for future earnings.


Welgene Biotech Co Retained Earnings Historical Data

* Premium members only.

The historical data trend for Welgene Biotech Co's Retained Earnings can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Welgene Biotech Co Retained Earnings Chart

Welgene Biotech Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Retained Earnings
Get a 7-Day Free Trial Premium Member Only Premium Member Only 13.68 9.59 -3.44 -2.33 -1.65

Welgene Biotech Co Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Retained Earnings Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -8.00 -1.00 -1.65 -7.94 -9.65
ROCO:6661
71GF Score
Welgene Biotech Co Ltd ROCO:6661
Retained Earnings is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Welgene Biotech Co Retained Earnings Calculation

Retained Earnings is the accumulated portion of net income that is not distributed to shareholders. Because the net income was not distributed to shareholders, shareholders' equity is increased by the same amount.

Of course, if a company loses, it is called retained losses, or accumulated losses.

Frequently Asked Questions Learn more about Retained Earnings →
What does a Retained Earnings of NT$-9.6 Mil mean?
Welgene Biotech Co (ROCO:6661) has a Retained Earnings of NT$-9.6 Mil as of Jun. 2026. Retained earnings is the amount of net income not issued to shareholders. View historical data on Welgene Biotech Co and its competitors.
Is Welgene Biotech Co's Retained Earnings too high?
Welgene Biotech Co's current Retained Earnings is NT$-9.6 Mil. Overall, Welgene Biotech Co has a GF Score™ of 71/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Welgene Biotech Co's Retained Earnings compare to TMO and DHR?
Welgene Biotech Co's Retained Earnings of NT$-9.6 Mil can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Retained Earnings for a Medical Diagnostics & Research company?
A good Retained Earnings depends on the Medical Diagnostics & Research industry context. However, Retained Earnings should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Retained Earnings mean?
A high Retained Earnings can signal that a stock is expensive relative to its fundamentals. Retained earnings is the amount of net income not issued to shareholders. View historical data on Welgene Biotech Co and its competitors. Welgene Biotech Co's current Retained Earnings is NT$-9.6 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Welgene Biotech Co stock overvalued right now?
Based on GuruFocus' analysis, Welgene Biotech Co (ROCO:6661) is currently considered Possible Value Trap. The stock's GF Value™ is NT$29.10, compared to a current price of NT$17.20 — trading 40.9% below its estimated fair value. The current Retained Earnings is NT$-9.6 Mil. Welgene Biotech Co's overall GF Score™ is 71/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Retained Earnings calculated?
Retained Earnings is calculated from a company's financial statements. For Welgene Biotech Co (ROCO:6661), the current Retained Earnings is NT$-9.6 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Welgene Biotech Co (ROCO:6661) Overvalued in 2026?

Based on GuruFocus' analysis, Welgene Biotech Co stock appears to be undervalued. The current stock price of NT$17.20 is trading 40.9% below its estimated GF Value™ of NT$29.10. GuruFocus considers Welgene Biotech Co to be Possible Value Trap.

Key valuation signals for ROCO:6661:

  • Retained Earnings: NT$-9.6 Mil
  • GF Value™: NT$29.10 vs. price of NT$17.20 (40.9% below fair value)
  • GF Score™: 71/100 with 6 warning signs

No single metric tells the full story. See the ROCO:6661 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Welgene Biotech Co Business Description

Address No. 3, Yuanqu Street, 12th Floor, Nangang District, Taipei, TWN, 115603
Welgene Biotech Co Ltd is engaged in providing genetic and biotechnology testing services and related products. Its offerings include next-generation sequencing (NGS) services, DNA microarray and PCR-based testing solutions, biotechnology reagents, diagnostic products, and laboratory instruments. The company also engages in the trading of medical and biotechnology equipment.
71GF Score

Get the complete analysis for ROCO:6661

Retained Earnings is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$17.20
Price
NT$29.10
GF Value